DBV Technologies (DBVT) Net Income (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Net Income of -$50.4 million for Q2 2026, down 20.29% year-on-year from -$63.2 million in Q2 2025, and down 5.88% on a QoQ basis from -$47.6 million in Q1 2026.

DBV Technologies (DBVT) Net Income (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Net Income for 7 consecutive years, with -$50.4 million the latest figure, recorded in Q2 2026.

  • Quarterly Net Income fell 20.29% year-over-year to -$50.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$176.0 million (down 43.72% YoY) and the FY2025 annual result came in at -$146.9 million, down 28.99% from the prior year.
  • Net Income fell to -$50.4 million in Q2 2026 per DBVT's latest filing, from -$47.6 million in the prior quarter.
  • Over the last five years, Net Income for DBVT reached as high as -$11.2 million in Q4 2023 and fell as low as -$50.4 million in Q2 2026.
  • A 5-year average of -$29.3 million and a median of -$27.2 million in 2024 frame the typical range for Net Income.
  • Annual changes were most pronounced in 2022 — Net Income slumped 187.02% — and 2023, when it jumped 71.49%.
  • Year by year, Net Income stood at -$39.2 million in 2022, then soared by 71.49% to -$11.2 million in 2023, then slumped by 105.75% to -$23.0 million in 2024, then slumped by 94.78% to -$44.8 million in 2025, then slipped by 12.43% to -$50.4 million in 2026.
  • According to Business Quant data, Net Income over the past three periods registered -$50.4 million, -$47.6 million, and -$44.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -37.09 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.31 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - -50.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -50.40 Mn
Mar 31, 2026 -47.60 Mn
Dec 31, 2025 -44.83 Mn
Sep 30, 2025 -33.16 Mn
Jun 30, 2025 -41.90 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 -23.02 Mn
Sep 30, 2024 -30.44 Mn
Jun 30, 2024 -33.12 Mn
Mar 31, 2024 -27.35 Mn
Dec 31, 2023 -11.19 Mn
Sep 30, 2023 -16.74 Mn
Jun 30, 2023 -24.24 Mn
Mar 31, 2023 -20.56 Mn
Dec 31, 2022 -39.24 Mn
Sep 30, 2022 -17.29 Mn
Jun 30, 2022 -23.04 Mn
Mar 31, 2022 -16.71 Mn
Dec 31, 2021 -13.67 Mn
Sep 30, 2021 -24.03 Mn